Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Baxter International (NY: BAX )

31.86 -0.04 (-0.14%)
Streaming Delayed Price Updated: 3:29 PM EST, Dec 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Baxter International

< Previous 1 2 3 4 5 6 7 Next >
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... 
Via Benzinga
Exposures Product Safety
Baxter's Norepinephrine Wins FDA Nod For Low Blood Pressure
The FDA has approved Baxter International Inc's (NYSE: BAX) premix norepinephrine bitartrate in 5% dextrose injection. Norepinephrine is indicated to raise blood pressure in... 
Via Benzinga
Exposures Product Safety
Stock Profile: Baxter International Inc.
Baxter International reported second-quarter sales increased a healthy 14% to $3.1 billion with net income increasing 22% to $301 million and EPS jumping 23% to $0.59. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2021
Upgrades For Bank of America Corp (NYSE: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 3, 2021
Upgrades Barclays upgraded the previous rating for Baxter International Inc (NYSE: 
Via Benzinga
Price To Earnings Ratio Insights For Baxter Intl
Looking into the current session, Baxter Intl Inc. (NYSE:BAX) shares are trading at $82.22, after a 5.95% rise. Moreover, over the past month, the stock spiked by 10... 
Via Benzinga
Baxter to Acquire Hillrom At $156/Share: See The Highlights
Baxter International Inc (NYSE: BAX) has agreed to acquire Hill-Rom Holdings Inc (NYSE: HRC) for $156.00 per share in cash, slightly higher than the earlier... 
Via Benzinga
2 Little-Followed Stocks That Are Soaring Monday
Markets were on the rise overall, but these companies were surprising in their gains. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Why Shares of Hill-Rom Holdings Are Surging This Morning
A previous buyout offer gets raised. 
Via The Motley Fool
Baxter In Advanced Talks For $10B Hill Rom Buyout: WSJ
The Wall Street Journal reported that Baxter International Inc (NYSE: BAX) is reportedly in advanced talks to Hill-Rom Holdings Inc (NYSE: HRC) for... 
Via Benzinga
Baxter International Inc (BAX) Under Pressure, Here’s The Trade
Baxter International Inc stock is now trading below its 200-week moving average. This puts the stock in a weak technical position on the charts and indicates lower stock prices ahead. 
Via Talk Markets
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, 21 companies made new 52-week lows. Interesting Highlights: Baxter Intl (NYSE:BAX) was the largest company by market cap to... 
Via Benzinga
Baxter Recalls Dose IQ Software 9.0.x Used With Infusion Pumps
The FDA issued a Class I recall, the most serious kind of recall, for Baxter International Inc's (NYSE: BAX) Dose IQ safety software used with Spectrum IQ... 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Got $5,000? These 3 Solid Dividend Stocks Are Trading Near Their 52-Week Lows
If you're an income investor, these investments should be on your radar right now. 
Via The Motley Fool
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, 77 companies made new 52-week lows. Areas of Interest: The largest company in terms of market cap to set a new 52-week low... 
Via Benzinga
Why Hill-Rom Stock Jumped 13% This Week
Earnings are due out tomorrow, but they won't be great. 
Via The Motley Fool
Baxter International Inc (BAX) Q2 2021 Earnings Call Transcript
BAX earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Baxter Q2 Earnings Marginally Beat Estimates; Revises Upper End Of 2021 EPS Outlook
Baxter International Inc (NYSE: BAX) Q2 revenue of $3.1 billion, in line with the consensus, increased 14% on a reported basis, 9% on a constant currency basis, and 8%... 
Via Benzinga
Why Shares of Hill-Rom Holdings Jumped Today
Reports of a bid for the company have lifted the stock. But there is no deal yet. 
Via The Motley Fool
Hill Rom Stock Shoots Higher As Baxter In Early Talks To Acquire Company: WSJ
According to people familiar with the matter, Baxter International Inc (NYSE: BAX) is reportedly in talks to buy Hill-Rom Holdings Inc (NYSE: HRC). The talks... 
Via Benzinga
Moderna's COVID-19 Vaccine Produced Neutralizing Titers Against All Variants Tested
Moderna Inc (NASDAQ: MRNA) has announced new results from in vitro neutralization studies of sera from individuals vaccinated with its COVID-19 vaccine. The COVID-... 
Via Benzinga
Exposures COVID-19
IPO Preview: Full Truck Alliance, Sprinklr, Mister Car Wash, Soulgate Lead Busy Week Of 10+ Offerings
The week of June 21 is setting up to be one of the busiest IPO weeks in some time with more than dozen companies that could go public with listings. Here is a look at some of the... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to... 
Via Benzinga
FDA Outlines Plan For Restarting Facility Inspections Halted Due To Pandemic
The FDA has published a roadmap for working through the backlog of facility inspections built up during the pandemic when it postponed all routine inspections in March... 
Via Benzinga
Exposures Product Safety
Baxter International Inc (BAX) Q1 2021 Earnings Call Transcript
BAX earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Tech Time: Microsoft, Advanced Micro Devices, Alphabet Reporting After Close Today
Ready or not, it’s time for all of us to put our Fed hats on. Again. It’s only been six weeks since the last Federal Open Market Committee (FOMC) meeting, but... 
Via Benzinga
Topics Economy
Exposures Interest Rates
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... 
Via Benzinga
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.